Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA…
High DAR Dual-Payload ADC Sutro unveils unique cell-free capabilities Proprietary cell-free platform enables the design of next-generation ADCs intended to…
– Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells –– Subcutaneous AK006 was well-tolerated…
Company’s Latest Communities Report Details Commitment to Responsible Development THE WOODLANDS, Texas, Oct. 10, 2024 (GLOBE NEWSWIRE) — Howard Hughes…